Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy

Chimeric antigen receptor (CAR) T cell therapy has demonstrated unprecedented feat in a variety of malignancies, providing a transformative approach to treating patients with hematological malignancies and solid tumors. Although CAR-T cell therapy has shown remarkable anti-tumor activity, toxicities...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yingying, Hu, Yongxian, Wang, Jiasheng, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651329/
http://dx.doi.org/10.31547/bct-2018-003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651329/
http://dx.doi.org/10.31547/bct-2018-003

Ejemplares similares